In the context of humans, mutations within the FATP1/SLC27A1 gene have been firmly linked to metabolic disorders, such as insulin resistance and type 2 diabetes, stemming from compromised cellular fatty acid uptake and utilization. This evidence concerns the gene SLC27A1 and metabolic disease.